Revaccination does not improve an observed deficit in antibody responses in Pakistani adults born of a lower birth weight

Vaccine

Volumn 26, Issue 2, 2008, Pages 158-165

  Moore, Sophie E ^a,b   Jalil, Fehmida ^c   Szu, Shousun Chen ^d   Hahn Zoric, Mirjana ^e   Prentice, Andrew M ^b   Hanson, Lars Å ^e  

^a MEDICAL RESEARCH COUNCIL LABORATORIES   (Gambia)

^b MEDICAL RESEARCH COUNCIL   (United Kingdom)

^c MAYO HOSPITAL   (Pakistan)

^d NATIONAL INSTITUTES OF HEALTH   (United States)

^e UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

Birth weight; Immune programming; Vaccine responses

Indexed keywords

HAEMOPHILUS INFLUENZAE TYPE B VACCINE; IMMUNOGLOBULIN G ANTIBODY; POLYSACCHARIDE VACCINE; TYPHOID VACCINE;

ADULT; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; FEMALE; HAEMOPHILUS INFLUENZAE TYPE B; HUMAN; INFLUENZA; LOW BIRTH WEIGHT; MAJOR CLINICAL STUDY; MALE; PAKISTAN; PRIORITY JOURNAL; REVACCINATION; SINGLE DRUG DOSE; TYPHOID FEVER; VACCINATION;

ADULT; ANTIBODIES, BACTERIAL; FEMALE; HAEMOPHILUS VACCINES; HUMANS; IMMUNIZATION, SECONDARY; IMMUNOGLOBULIN G; INFANT, LOW BIRTH WEIGHT; INFANT, NEWBORN; MALE; PAKISTAN; POLYSACCHARIDES, BACTERIAL; TYPHOID-PARATYPHOID VACCINES; VACCINES, CONJUGATE;

EID: 37449021722     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2007.11.007     Document Type: Article

References (25)

1. Byrne C.D., and Phillips D.I. Fetal origins of adult disease: epidemiology and mechanisms. J Clin Pathol 53 11 (November) (2000) 822-828
2. Moore S.E., Collinson A.C., Tamba N'gom P., Aspinall R., and Prentice A.M. Early immunological development and mortality from infectious disease in later life. Proc Nutr Soc 65 3 (August) (2006) 311-318
3. McDade T.W., Beck M.A., Kuzawa C., and Adair L.S. Prenatal undernutrition, postnatal environments, and antibody response to vaccination in adolescence. Am J Clin Nutr 74 4 (October) (2001) 543-548
4. Moore S.E., Jalil F., Ashraf R., Szu S.C., Prentice A.M., and Hanson L.A. Birth weight predicts response to vaccination in adults born in an urban slum in Lahore, Pakistan. Am J Clin Nutr 80 (2004) 453-459
5. Weller S., Reynaud C.A., and Weill J.C. Vaccination against encapsulated bacteria in humans: paradoxes. Trends Immunol 26 2 (February) (2005) 85-89
6. Schlesinger Y., and Granoff D.M. Avidity and bactericidal activity of antibody elicited by different Haemophilus influenzae type b conjugate vaccines. The Vaccine Study Group. JAMA 267 11 (March) (1992) 1489-1494
7. Goldblatt D., Vaz A.R., and Miller E. Antibody avidity as a surrogate marker of successful priming by Haemophilus influenzae type b conjugate vaccines following infant immunization. J Infect Dis 177 4 (April) (1998) 1112-1115
8. Mellander L., Bottiger M., Hanson L.A., Taranger J., and Carlsson B. Avidity and titers of the antibody response to two inactivated poliovirus vaccines with different antigen content. Acta Paediatr 82 6-7 (June-July) (1993) 552-556
9. Jalil F., Karlberg J., Hanson L.A., and Lindblad B.S. Growth disturbance in an urban area of Lahore, Pakistan related to feeding patterns, infections and age, sex, socio-economic factors and seasons. Acta Paediatr Scand Suppl 350 (1989) 44-54
10. Kossaczka Z., Lin F., Ho V.A., Thuy N.T.T., Bay P.V., Thanh T.C., et al. Safety and immunogenicity of Vi conjugate vaccines for typhoid fever in adults, teenagers, and 2- to 4-year-old children in Vietnam. Infect Immun 67 (1999) 5806-5810
11. Pullen G.R., Fitzgerald M.G., and Hosking C.S. Antibody avidity determination by ELISA using thiocyanate elution. J Immunol Methods 86 1 (January) (1986) 83-87
12. Roberton D.M., Carlsson B., Coffman K., Hahn-Zoric M., Jalil F., Jones C., et al. Avidity of IgA antibody to Escherichia coli polysaccharide and diphtheria toxin in breast milk from Swedish and Pakistani mothers. Scand J Immunol 28 6 (December) (1988) 783-789
13. Sutton A., Vann W.F., Karpas A.B., Stein K.E., and Schneerson R. An avidin-biotin based ELISA for quantitation of antibody to bacterial polysaccharides. J Immunol Methods 82 2 (October) (1985) 215-224
14. WHO. Measuring change in nutritional status; 1983.
15. Holt P., Naspitz C., and Warner J.O. Early immunological influences. Chem Immunol Allergy 84 (2004) 102-127
16. Collinson A.C., Moore S.E., Cole T.J., and Prentice A.M. Birth season and environmental influences on patterns of thymic growth in rural Gambian infants. Acta Paediatr 92 9 (September) (2003) 1014-1020
17. N'Gom P.T., Collinson A.C., Pido-Lopez J., Henson S.M., Prentice A.M., and Aspinall R. Improved thymic function in exclusively breastfed infants is associated with higher interleukin 7 concentrations in their mothers' breast milk. Am J Clin Nutr 80 (2004) 722-728
18. Keitel W.A., Bond N.L., Zahradnik J.M., Cramton T.A., and Robbins J.B. Clinical and serological responses following primary and booster immunization with Salmonella typhi Vi capsular polysaccharide vaccines. Vaccine 12 3 (1994) 195-199
19. Ada G., and Isaacs D. Carbohydrate-protein conjugate vaccines. Clin Microbiol Infect 9 2 (February) (2003) 79-85
20. Claesson B.A., Schneerson R., Trollfors B., Lagergard T., Taranger J., and Robbins J.B. Duration of serum antibodies elicited by Haemophilus influenzae type b capsular polysaccharide alone or conjugated to tetanus toxoid in 18- to 23-month-old children. J Pediatr 116 6 (June) (1990) 929-931
21. Moore S.E., Collinson A.C., Fulford A.J., Jalil F., Siegrist C.A., Goldblatt D., et al. Effect of month of vaccine administration on antibody responses in The Gambia and Pakistan. Trop Med Int Health 11 10 (2006) 1529-1541
22. Singhal A., and Lucas A. Early origins of cardiovascular disease: is there a unifying hypothesis?. Lancet 363 9421 (May) (2004) 1642-1645
23. Hanson L.A. Session 1: feeding and infant development breast-feeding and immune function. Proc Nutr Soc 66 3 (August) (2007) 384-396
24. Lane P. Are polysaccharide antibody responses independent: the T cell enigma?. Clin Exp Immunol 105 1 (July) (1996) 10-11
25. Lin F.Y., Ho V.A., Khiem H.B., Trach D.D., Bay P.V., Thanh T.C., et al. The efficacy of a Salmonella typhi Vi conjugate vaccine in two-to-five-year-old children. N Engl J Med 344 17 (April) (2001) 1263-1269